No new ‘mabs’ in medicine – New nomenclature for monoclonal antibodies
File(s)
Accepted version
Author(s)
Lythgoe, Mark
Type
Journal Article
Date Issued
2022-12
Date Acceptance
2022-09-23
Citation
British Journal of Pharmacology, 2022, 179 (24), pp.5338-5339
ISSN
0007-1188
Publisher
Wiley
Start Page
5338
End Page
5339
Journal / Book Title
British Journal of Pharmacology
Volume
179
Issue
24
Copyright Statement
© 2022 The British Pharmacological Society. This is the peer reviewed version of the following article, which has been published in final form at https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bph.15953. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.
Identifier
https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.15953
Subjects
Science & Technology
Life Sciences & Biomedicine
Pharmacology & Pharmacy
Antibodies, Monoclonal
Antineoplastic Agents, Immunological
Antibodies, Monoclonal
Antineoplastic Agents, Immunological
Pharmacology & Pharmacy
1115 Pharmacology and Pharmaceutical Sciences
Publication Status
Published
Date Publish Online
2022-09-27